Suchergebnisse - "Klöhn, Mara"

PubPharm (22)

1

Dynamic evolution of the sofosbuvir-associated variant A1343V in HEV-infected patients under concomitant sofosbuvir-ribavirin treatment

enthalten in: JHEP reports : innovation in hepatology | 2024

von Gömer, A. | Dinkelborg, K. | Klöhn, M. | +10

2

Host determinants and responses underlying SARS-CoV-2 liver tropism

enthalten in: Current opinion in microbiology | 2024

von Heinen, N. | Klöhn, M. | Westhoven, S. | +2

3

Halogenated Rocaglate Derivatives : Pan-antiviral Agents against Hepatitis E Virus and Emerging Viruses

enthalten in: Journal of medicinal chemistry | 2024

von Victoria, C. | Schulz, G. | Klöhn, M. | +9

4

Productive infection of primary human hepatocytes with SARS-CoV-2 induces antiviral and proinflammatory responses

enthalten in: Gut | 2023

von Heinen, N. | Khanal, R. | Westhoven, S. | +12

5

Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Gömer, A. | Klöhn, M. | Jagst, M. | +11

6

Targeting cellular cathepsins inhibits hepatitis E virus infection

enthalten in: bioRxiv.org | 2023

von Klöhn, M. | Burkard, T. | Janzen, J. | +8

7

A high-content RNA-based imaging assay reveals integrin beta 1 as a cofactor for cell entry of non-enveloped hepatitis E virus

enthalten in: bioRxiv.org | 2023

von Fu, R. | Engels, Z. | Weihs, J. | +9

8

Janus kinase-inhibition modulates hepatitis E virus infection

enthalten in: Antiviral research | 2023

von Kinast, V. | Andreica, I. | Ahrenstorf, G. | +15

9

Janus kinase-inhibition modulates hepatitis E virus infection

enthalten in: Antiviral research | 2023

von Kinast, V. | Andreica, I. | Ahrenstorf, G. | +8

10

Halogenated Rocaglate Derivatives: Pan-antiviral Agents against Hepatitis E Virus and Emerging Viruses

sonderdruck aus: Journal of Medicinal Chemistry (formerly: Journal of Medicinal and Pharmaceutical Chemistry) | 2023

von Victoria, C. | Schulz, G. | Klöhn, M. | +9